about
Microglial migration and interactions with dendrimer nanoparticles are altered in the presence of neuroinflammation.Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model.Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers.Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.Stimuli-responsive star poly(ethylene glycol) drug conjugates for improved intracellular delivery of the drug in neuroinflammationTransport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates.Inhibition of bacterial growth and intramniotic infection in a guinea pig model of chorioamnionitis using PAMAM dendrimers.Intrauterine administration of endotoxin leads to motor deficits in a rabbit model: a link between prenatal infection and cerebral palsy.Concurrent quantification of tryptophan and its major metabolites.Augmented annotation and orthologue analysis for Oryctolagus cuniculus: Better BunnyOropharyngeal dermoid cyst in an infant with intermittent airway obstruction. A case report.Decreased cortical serotonin in neonatal rabbits exposed to endotoxin in uteroPredictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery.Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration.Magnitude of [(11)C]PK11195 binding is related to severity of motor deficits in a rabbit model of cerebral palsy induced by intrauterine endotoxin exposure.A New Rabbit Model of Pediatric Traumatic Brain Injury.Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injuryInjectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluationIntrauterine endotoxin administration leads to white matter diffusivity changes in newborn rabbits.Poly(amidoamine) dendrimer-drug conjugates with disulfide linkages for intracellular drug delivery.Nanomedicine in cerebral palsy.Dendrimer-drug conjugates for tailored intracellular drug release based on glutathione levels.Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.Maternal endotoxin exposure results in abnormal neuronal architecture in the newborn rabbitApplications of positron emission tomography in the newborn nursery.Biodistribution of fluorescently labeled PAMAM dendrimers in neonatal rabbits: effect of neuroinflammation.Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest.Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.Models of fetal brain injury, intrauterine inflammation, and preterm birth.Emerging concepts in dendrimer-based nanomedicine: from design principles to clinical applications.Targeting specific cells in the brain with nanomedicines for CNS therapiesNanotechnology Approaches to Targeting Inflammation and Excitotoxicity in a Canine Model of Hypothermic Circulatory Arrest-Induced Brain InjuryEffects of branching architecture and linker on the activity of hyperbranched polymer-drug conjugates.The effect of surface functionality on cellular trafficking of dendrimers.Preparation, cellular transport, and activity of polyamidoamine-based dendritic nanodevices with a high drug payload.Synthesis, cellular transport, and activity of polyamidoamine dendrimer-methylprednisolone conjugates.Hyperbranched polymer-drug conjugates with high drug payload for enhanced cellular delivery.Maternal dendrimer-based therapy for inflammation-induced preterm birth and perinatal brain injury.Maternal inflammation leads to impaired glutamate homeostasis and up-regulation of glutamate carboxypeptidase II in activated microglia in the fetal/newborn rabbit brain.Nanoscale effects in dendrimer-mediated targeting of neuroinflammation
P50
Q27303218-6ECD5C4F-0686-4FF2-9F65-4C17CC86BB5CQ30528069-EFE8B128-235B-4B61-8697-DED79AE22308Q30800406-DA95EC04-D0DB-46A6-865C-29FF18FD247BQ33563098-991EEE20-BDFC-4083-B468-3FB2126083DCQ33708080-B90741C9-E70E-425E-8F84-691427A7C3E9Q33896898-AAD48F3E-B622-4DA4-A40D-6C2D647D4DCAQ34012976-B53D72D3-433C-4E89-8F95-BB1C197B0ED4Q34034281-FAB8D3B1-362C-477C-B111-8ED6F6FC3FC7Q34118912-A2810856-71C7-4385-9204-C6541DCF7F30Q34262331-1138C54B-B92D-4F85-BCE6-EDF4FB20CB5CQ34540952-68E91E6B-FF4A-4059-8F79-C6889F5CA211Q34627661-C358AF06-75DE-4F0C-92C9-0673E34E8DF1Q34978166-A067D07D-D655-42EA-8358-F2EFF016E852Q34983738-7032FA16-79A6-479E-9D41-164F63F68A9DQ35576378-A4EC807C-F3CC-4451-A513-A0B22DBBBF20Q35977648-3F8ED654-BFA7-4B47-A471-C87DCED73653Q36520379-E1CC188E-E97B-45AC-9B6F-E81574FCCDB7Q36566183-F43BCE95-C69C-49B6-AC9E-F84AD78B3D76Q36925279-0A8EAEA5-F8DF-4ABB-A883-93FA0B9DD6F2Q37216165-8A847614-8390-442F-93F6-5A7A041651B4Q37281194-1E127002-827C-46E7-BB3D-DC3347B853C1Q37307526-88A97287-8EC2-4603-A483-807975310954Q37567601-E19C3090-44BF-48BC-9F65-ACF8ED3A1F4FQ37568482-2367EF25-C09C-4B2E-BF84-AD3AFD3DE51DQ37683151-8649483D-1851-4A1D-AA99-B63ACE2286B7Q37687066-4F248351-F161-4F50-95F8-F886D6765CCEQ37731623-0D478681-A5C6-4666-9284-20979C120A6DQ37737065-16B05802-7894-46DB-A074-4320CFA0AAFBQ37989540-4F8C396D-3CC9-40C7-BCEF-FDEB83A84153Q38226315-DB5DBFD3-0DFB-4F81-821A-56DE60131665Q38674279-A403BEC2-2077-4A43-BBC3-C7032C7AC287Q38870477-22548B20-3259-4561-87F9-ED13F5E123E6Q39858988-7230FA19-E896-4BAE-AAA6-E028BF3B7D5EQ39978998-B03EF18B-55DD-42C6-A297-C8E83E2F6504Q40391415-4D9C8D97-ADCF-4B6F-B9C0-4257814A4F44Q40446549-1479E9E0-CB14-41E7-A2BB-355C2D167E20Q40472015-4C9EBA68-A51F-49CD-ABB4-EF31223005D9Q41094809-3EEDBE4F-57D1-4B96-89BB-31B28EA1E0EBQ41654351-5EA444B9-FFCC-4733-B412-2036495BCFF8Q41992016-ABF0824E-14EF-44AB-8EDC-741D751B2271
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sujatha Kannan
@ast
Sujatha Kannan
@en
Sujatha Kannan
@es
Sujatha Kannan
@nl
type
label
Sujatha Kannan
@ast
Sujatha Kannan
@en
Sujatha Kannan
@es
Sujatha Kannan
@nl
prefLabel
Sujatha Kannan
@ast
Sujatha Kannan
@en
Sujatha Kannan
@es
Sujatha Kannan
@nl
P106
P1153
8902662300
P21
P31
P496
0000-0002-9497-5786